Megan Sutton is Executive Medical Director, Clinical Development and Real-World Evidence of Lexeo Therapeutics based in 345 Park Avenue South 6th Floor New York, New York 10010, US. Previously worked at Renovacor as a Global Head of Medical Affairs, Executive Director. Lexeo Therapeutics is a Manufacturing, Pharmaceuticals company in 345 Park Avenue South 6th Floor New York, New York 10010, US with 70 employees.
Megan Sutton has 25 years of professional experience, with an average of 2 years per position throughout their career. Their recent employment history shows 0 changes in the past 3 years, with high job stability. they have Fortune 500 company experience.
Megan Sutton have a experience in top university. Megan Sutton holds a masters,master of science in nursing degree from columbia university school of nursing, with 19 years since graduation. Their career include experience at a global enterprise.
Lexeo Therapeutics is founded in 2018, operates from its headquarter in 345 Park Avenue South 6th Floor New York, New York 10010, US. The company operates in the Manufacturing, Pharmaceuticals sector.
Lexeo Therapeutics specializes in Gene therapy research, Rare disease drug development, Manufacturing of genetic medicines, Commercialization of genetic therapies, and offers services including Genetic medicines, Cardiovascular disease treatments, and Alzheimer's disease treatments.
Lexeo Therapeutics has hired 1 new employees in the past 6 months, including 1 C-level executives..
Megan Sutton completed at columbia university school of nursing (2003 - 2007) , at georgetown university (1997 - 2001) , etc
These email and Phone numbers are the most updated and verified contact information for Megan Sutton found in 2025.